• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?

作者信息

Ehtesham Nasreen Zafar, Samal Jasmine, Ahmad Faraz, Arish Mohd, Naz Farha, Alam Anwar, Agrawal Usha, Hasnain Seyed Ehtesham

机构信息

Inflammation Biology & Cell Signaling Laboratory, ICMR-National Institute of Pathology, New Delhi 110 029, India.

Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110 062, India.

出版信息

Indian J Med Res. 2020;152(1 & 2):16-20. doi: 10.4103/ijmr.IJMR_1563_20.

DOI:10.4103/ijmr.IJMR_1563_20
PMID:32859863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7853263/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac8/7853263/2e618e3d1ba9/IJMR-152-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac8/7853263/2e618e3d1ba9/IJMR-152-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac8/7853263/2e618e3d1ba9/IJMR-152-16-g001.jpg

相似文献

1
Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?卡介苗免疫接种能阻止新冠疫情吗？
Indian J Med Res. 2020;152(1 & 2):16-20. doi: 10.4103/ijmr.IJMR_1563_20.
2
COVID-19 and Bacillus Calmette-Guérin: What is the Link?新型冠状病毒肺炎与卡介苗：有何关联？
Eur Urol Oncol. 2020 Jun;3(3):259-261. doi: 10.1016/j.euo.2020.04.001. Epub 2020 Apr 13.
3
Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?卡介苗（BCG）接种用于抗击新冠疫情——旧药新用？
Future Oncol. 2020 Jul;16(19):1323-1325. doi: 10.2217/fon-2020-0381. Epub 2020 May 14.
4
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.卡介苗（BCG）接种在 COVID-19 大流行死亡率中的潜在作用：流行病学和免疫学方面。
Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863.
5
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护：丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
6
Keeping track of the SARS-CoV-2 vaccine pipeline. 跟踪 SARS-CoV-2 疫苗研发管线。
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
7
Is BCG vaccination affecting the spread and severity of COVID-19?卡介苗接种会影响新冠病毒疾病（COVID-19）的传播和严重程度吗？
Allergy. 2020 Jul;75(7):1824-1827. doi: 10.1111/all.14344. Epub 2020 May 12.
8
BCG-induced trained immunity: can it offer protection against COVID-19?BCG 诱导的训练免疫：能提供针对 COVID-19 的保护吗？
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.
9
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.卡介苗（BCG）疫苗与新冠疫情：需要负责任的管理。
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):732-734. doi: 10.5588/ijtld.20.0267.
10
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Jun 3;16(696):1174-1175.

引用本文的文献

1
Relationship between Tuberculin Skin Test and COVID-19 Outcomes among Patients with COVID-19 in Zahedan, Iran.伊朗扎黑丹新冠肺炎患者结核菌素皮肤试验与新冠肺炎结局的关系
Tanaffos. 2022 Feb;21(2):154-160.
2
Clinical impact of COVID-19 on tuberculosis.新型冠状病毒肺炎对结核病的临床影响。
Infez Med. 2022 Dec 1;30(4):495-500. doi: 10.53854/liim-3004-3. eCollection 2022.
3
COVID-19 and tuberculosis: the double whammy of respiratory pathogens.新型冠状病毒肺炎与结核病：呼吸道病原体的双重打击。

本文引用的文献

1
SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.SARS-CoV-2 与 COVID-19：遗传、流行病学和进化角度的分析。
Infect Genet Evol. 2020 Oct;84:104384. doi: 10.1016/j.meegid.2020.104384. Epub 2020 May 29.
2
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?全球卡介苗接种诱导的训练免疫与SARS-CoV-2大流行的进展相关吗？
Allergy. 2020 Jul;75(7):1815-1819. doi: 10.1111/all.14345. Epub 2020 Jun 8.
3
Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today.
Eur Respir Rev. 2022 Apr 13;31(164). doi: 10.1183/16000617.0264-2021. Print 2022 Jun 30.
4
Role of multiple factors likely contributing to severity-mortality of COVID-19.多种因素在导致 COVID-19 严重程度和死亡率方面的作用。
Infect Genet Evol. 2021 Dec;96:105101. doi: 10.1016/j.meegid.2021.105101. Epub 2021 Oct 5.
SARS-CoV-2 临床分离株中新兴的遗传多样性：今日的教训。
Infect Genet Evol. 2020 Oct;84:104330. doi: 10.1016/j.meegid.2020.104330. Epub 2020 Apr 24.
4
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
5
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia.新型减毒结核疫苗 MTBVAC 可诱导训练性免疫，并对实验性致死性肺炎提供保护。
PLoS Pathog. 2020 Apr 2;16(4):e1008404. doi: 10.1371/journal.ppat.1008404. eCollection 2020 Apr.
6
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
7
Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology.结核病疫苗接种：免疫导向的分子遗传学改造卡介苗。
Front Immunol. 2020 Feb 27;11:316. doi: 10.3389/fimmu.2020.00316. eCollection 2020.
8
Defining trained immunity and its role in health and disease.定义训练免疫及其在健康和疾病中的作用。
Nat Rev Immunol. 2020 Jun;20(6):375-388. doi: 10.1038/s41577-020-0285-6. Epub 2020 Mar 4.
9
Revisiting BCG to control tuberculosis: mucosal delivery and delipidation?重新审视卡介苗以控制结核病：黏膜给药与去脂化？
Lancet Infect Dis. 2020 Mar;20(3):272-273. doi: 10.1016/S1473-3099(19)30702-9.
10
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.